Literature DB >> 30894671

Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.

Tsukasa Doki1, Satoshi Yamashita2, Fan-Yan Wei3, Kentaro Hara1, Takahiro Yamamoto3, Ziwei Zhang1, Xiao Zhang1, Nozomu Tawara1, Hirotake Hino4, Eiichiro Uyama5, Takashi Kurashige6,7, Hirofumi Maruyama7, Kazuhito Tomizawa3,8, Yukio Ando1,8.   

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disorder characterized by ptosis, dysphagia, and weakness of proximal limbs. OPMD is caused by the expansion of polyalanine in poly(A)-binding protein, nuclear 1 (PABPN1). Although mitochondrial abnormality has been proposed as the possible etiology, the molecular pathogenesis is still poorly understood. The aim of the study was to specify the mechanism by which expanded PABPN1 causes mitochondrial dysfunction in OPMD. We evaluated whether transgenic mouse model of OPMD, by expressing expanded PABPN1, indeed causes mitochondrial abnormality associated with muscle degeneration. We also investigated the mechanism by which expanded PABPN1 would cause mitochondrial dysfunction in the mouse and cell models of OPMD. Mitochondrial localization of PABPN1 was observed in the muscle fibers of patients with OPMD. Moreover, abnormal accumulation of PABPN1 on the inner membrane of mitochondria and reduced expression of OXPHOS complexes were detected in the muscle fibers of the transgenic mice expressing expanded human PABPN1 with a 13-alanine stretch. In cells expressing PABPN1 with a 10-alanine or 18-alanine stretch, both types of PABPN1 accumulated in the mitochondria and interacted with TIM23 mitochondrial protein import complex, but PABPN1 with 18-alanine stretch decreased the cell viability and aggresome formation. We proposed that the abnormal accumulation of expanded PABPN1 in mitochondria may be associated with mitochondrial abnormality in OPMD.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30894671     DOI: 10.1038/s41374-019-0243-8

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

1.  CGG repeat expansion in NOTCH2NLC causes mitochondrial dysfunction and progressive neurodegeneration in Drosophila model.

Authors:  Jiaxi Yu; Tongling Liufu; Yilei Zheng; Jin Xu; Lingchao Meng; Wei Zhang; Yun Yuan; Daojun Hong; Nicolas Charlet-Berguerand; Zhaoxia Wang; Jianwen Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

2.  Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons.

Authors:  Tomonori Hara; Manabu Toyoshima; Yasuko Hisano; Shabeesh Balan; Yoshimi Iwayama; Harumi Aono; Yushi Futamura; Hiroyuki Osada; Yuji Owada; Takeo Yoshikawa
Journal:  Transl Psychiatry       Date:  2021-05-08       Impact factor: 6.222

Review 3.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

4.  Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy.

Authors:  Rosemarie H M J M Kroon; Johanna G Kalf; Bert J M de Swart; Barbara M van der Sluijs; Jeffrey C Glennon; Vered Raz; Baziel G van Engelen; Corinne G C Horlings
Journal:  Neurology       Date:  2021-08-11       Impact factor: 9.910

5.  Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).

Authors:  Sylvia Nieuwenhuis; Joanna Widomska; Paul Blom; Peter-Bram A C 't Hoen; Baziel G M van Engelen; Jeffrey C Glennon
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.